The expert from the Centre Hospitalier Lyon-Sud discussed the results of a phase II study of avelumab for patients with GTT who were resistant to chemotherapy.
Benoit You, MD, PhD
Advertisement
Articles by Benoit You, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Tocilizumab Supports Outpatient Bispecific Antibody Use in Multiple Myeloma
2
GLP-1 Receptor Agonists May Improve Survival, Reduce irAEs in ICI-Treated Patients
3
Perioperative Apalutamide Shifts Standard in Localized, High-Risk Prostate Cancer
4
ASCENT-04 Subgroup Analysis Yields Consistent PFS Benefits in Metastatic TNBC
5